Neurofeedback, as treatment for a variety of psychiatric
problems, has an abundance of supportive research evidence.
Recently, a special issue of Child and Adolescent
Psychiatric Clinics of North America was devoted to
emerging interventions concerning brain function. Seven of
the ten chapters in the volume included Neurofeedback. The
editors, in providing a summary and clinical perspective on
all the featured approaches, concluded in relation to
Neurofeedback:
“EEG biofeedback meets the American Academy
of Child and Adolescent Psychiatry criteria for clinical
guideline (CG) for treatment of ADHD, seizure disorders,
anxiety (OCD, GAD, PTSD, phobias), depression, reading
disabilities, and addictive disorders.
This suggests that EEG biofeedback should
always be considered as an intervention for these disorders
by the clinician." |